Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

The aqueous extract of Gerrardanthus macrorhizus caudex enhanced doxorubicin activity in MCF-7 human breast cancer cells

Indonesian Journal of Biotechnology · Vol. 23 No. 1 (2018) · hlm. 7–13

DOI
10.22146/ijbiotech.32519
ISSN
2089-2241, 0853-8654
Terbit
2018-06-11
Penerbit
Universitas Gadjah Mada
Bahasa
eng
Lisensi
creativecommons.org/licenses/by-sa/4.0

Abstrak

Gerrardanthus macrorhizus (GM) caudex, is traditionally used in cancer therapy by the Tetun people in Belu District, East Nusa Tenggara Province, Indonesia, where it is known as “akar batu”. This study aimed to explore the cytotoxic effects of G. macrorhizus caudex aqueous extract, as well as its combination with doxorubicin, on MCF-7 cells. Also investigated were the possible mechanisms of interaction through cell cycle progression and apoptosis induction. Single treatments of 5–320 µg/mL of the extract showed morphological alterations in MCF-7 cells, but did not show any cytotoxic effect. Combining the extract with doxorubicin resulted in a synergistic cytotoxic effect. Doxorubicin concentrations equivalent to 1/12, 1/8, and 1/5 fold of the IC50 combined with 20 µg/mL decreased viability to 48%. We then explored the combination effect of doxorubicin 0.4 µM with GM 5 and 20 µg/mL using a flow cytometer. A low concentration of the extract (5 µg/mL) combined with 0.4 µM of doxorubicin resulted in slight cell cycle modulation by G1, G2M arrested and apoptosis induction. The combination of doxorubicin and a higher concentration of the extract (20 µg/mL) did not show cell cycle modulation, and led to necrosis. Therefore, G. macrorhizus caudex at low concentrations has the potential to be developed further as a co-chemotherapeutic agent.

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 150 tautan kepenulisan bersama · 77 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Universitas Gadjah Mada
  • National Research and Innovation Agency
  • Kementerian Kesehatan Republik Indonesia
  • Muhammadiyah University of Surakarta
  • University of Bengkulu
  • Atma Jaya University Yogyakarta
  • Lambung Mangkurat University
  • Organisasi lain
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Edy MeiyantoUniversitas Gadjah Mada5
Dyah SubositiKementerian Kesehatan Republik Indonesia3
Rohmat MujahidKementerian Kesehatan Republik Indonesia3
Suwijiyo PramonoUniversitas Gadjah Mada2
Retno MurwantiUniversitas Gadjah Mada2
Herwandhani PutriUniversitas Gadjah Mada2
Dian SusantiKementerian Kesehatan Republik Indonesia2
Aditya Dwi Permana PutraNational Research and Innovation Agency2
Devi SafrinaKementerian Kesehatan Republik Indonesia2
Nur Rahmawati WijayaKementerian Kesehatan Republik Indonesia2
M Bakti Samsu AdiNational Research and Innovation Agency2
Rizal Maarif RukmanaNational Research and Innovation Agency2
Usman SiswantoUniversity of Bengkulu2
Nina KurnianingrumKementerian Kesehatan Republik Indonesia1
Sendy JunediAtma Jaya University Yogyakarta1
Subagus WahyuonoUniversitas Gadjah Mada1
Rarastoeti PratiwiUniversitas Gadjah Mada1
Sugeng RiyantoUniversitas Gadjah Mada1
Endah RetnaningrumUniversitas Gadjah Mada1
Ratna Asmah SusidartiUniversitas Gadjah Mada1
Rozana ZuhriUniversitas Gadjah Mada1
Muhammad Da’iMuhammadiyah University of Surakarta1
Khairunnisa Azani MeilinasaryAfiliasi tidak diketahui1
Andi SuhendiMuhammadiyah University of Surakarta1
Puguh IndrasetiawanUniversitas Gadjah Mada1
Ediati SasmitoUniversitas Gadjah Mada1
Dhania NovitasariUniversitas Gadjah Mada1
Beni LestariUniversitas Gadjah Mada1
Gagas Pradani Nur IlmawatiUniversitas Gadjah Mada1
Dina ApriliaLambung Mangkurat University1
Sri Rejeki HandayaniNational Research and Innovation Agency1
Vita Taufika RosyidaIndonesian Institute of Sciences1
Andri FrediansyahNational Research and Innovation Agency1
Khoirun NisaNational Research and Innovation Agency1
Martha Purnami WulanjatiNational Research and Innovation Agency1
Anjar WindarsihNational Research and Innovation Agency1
Cici DarsihNational Research and Innovation Agency1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) https://jurnal.ugm.ac.id/ijbiotech/oai, pertama di-harvest 8 Nov 2026, terakhir terlihat 16 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">The aqueous extract of Gerrardanthus macrorhizus caudex enhanced doxorubicin activity in MCF-7 human breast cancer cells</dc:title>
	<dc:creator>Haryanti, Sari</dc:creator>
	<dc:creator>Widiyastuti, Yuli</dc:creator>
	<dc:creator>Wahyono, Slamet</dc:creator>
	<dc:subject xml:lang="en-US">apoptosis; cell cycle; cytotoxic; doxorubicin; Gerrardanthus macrorhizus; MCF-7</dc:subject>
	<dc:description xml:lang="en-US">Gerrardanthus macrorhizus (GM) caudex, is traditionally used in cancer therapy by the Tetun people in Belu District, East Nusa Tenggara Province, Indonesia, where it is known as “akar batu”. This study aimed to explore the cytotoxic effects of G. macrorhizus caudex aqueous extract, as well as its combination with doxorubicin, on MCF-7 cells. Also investigated were the possible mechanisms of interaction through cell cycle progression and apoptosis induction. Single treatments of 5–320 µg/mL of the extract showed morphological alterations in MCF-7 cells, but did not show any cytotoxic effect. Combining the extract with doxorubicin resulted in a synergistic cytotoxic effect. Doxorubicin concentrations equivalent to 1/12, 1/8, and 1/5 fold of the IC50 combined with 20 µg/mL decreased viability to 48%. We then explored the combination effect of doxorubicin 0.4 µM with GM 5 and 20 µg/mL using a flow cytometer. A low concentration of the extract (5 µg/mL) combined with 0.4 µM of doxorubicin resulted in slight cell cycle modulation by G1, G2M arrested and apoptosis induction. The combination of doxorubicin and a higher concentration of the extract (20 µg/mL) did not show cell cycle modulation, and led to necrosis. Therefore, G. macrorhizus caudex at low concentrations has the potential to be developed further as a co-chemotherapeutic agent.</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Gadjah Mada</dc:publisher>
	<dc:contributor xml:lang="en-US"></dc:contributor>
	<dc:date>2018-06-11</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Original Research Articles</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.ugm.ac.id/ijbiotech/article/view/32519</dc:identifier>
	<dc:identifier>10.22146/ijbiotech.32519</dc:identifier>
	<dc:source xml:lang="en-US">Indonesian Journal of Biotechnology; Vol 23, No 1 (2018); 7-13</dc:source>
	<dc:source>2089-2241</dc:source>
	<dc:source>0853-8654</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://journal.ugm.ac.id/ijbiotech/article/view/32519/21229</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2018 The Author(s)</dc:rights>
	<dc:rights xml:lang="en-US">http://creativecommons.org/licenses/by-sa/4.0</dc:rights>
</oai_dc:dc>